| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |